Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
D
Details...
Enter Symbol
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)
Sector: Medical
Current Price :
$79.47
52 Week Low
$35.56
52 Week High
$85.60
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
218M
Market Cap:
$18.68B
Avg Volume:
2892833
P/E Ratio:
129.700
PEG Ratio:
-0.010
Split:
On 8/24/2000 vrtx split by factor of 2.000
1m
3m
6m
1y
2y
Opinion and Analysis
Vertex Pharmaceuticals Incorporated: Who Should VRTX Partner In HCV - JNJ or BMY?
May 07, 2013 10:05 AM |
BMY
,
JNJ
,
VRTX
Stocks End Higher Amid Mixed Earnings; IBM Plunges
Apr 19, 2013 04:08 PM |
AIRM
,
CMG
,
GE
,
GOOG
,
HON
,
IBM
Stock Upgrades And Downgrades: AN, COH, COT, EE, PAY, NOK, VRTX, WWW
Apr 19, 2013 10:28 AM |
AN
,
COH
,
COT
,
EE
,
NOK
,
PAY
More Articles on VRTX..
Press Releases
Vertex Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015
May 17, 2013 08:30 AM |
VRTX
Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences
May 09, 2013 06:07 PM |
VRTX
Free Research Reports on AVEO, CXO, MWW and VRTX Issued by the Paragon Report
May 03, 2013 08:20 AM |
CXO
,
VRTX
More Press Releases on VRTX..
SEC Filings
Form 4 VERTEX PHARMACEUTICALS For: Feb 05 Filed by: Stamoulis Christiana (10K)
Feb 07, 2013 05:53 PM
Form 4 VERTEX PHARMACEUTICALS For: Feb 05 Filed by: SMITH IAN F (10K)
Feb 07, 2013 05:53 PM
Form 4 VERTEX PHARMACEUTICALS For: Feb 05 Filed by: Sachdev Amit (10K)
Feb 07, 2013 05:51 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
VRTX
Compare to S&P
YTD
104.30 %
87.34 %
4 Weeks
59.28 %
59.45 %
12 Weeks
82.71 %
76.57 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-0.01 %
EPS Growth in Last Year:
-110.67 %
Sales Growth in Last Quarter:
-0.60 %
Sales Growth in Last Quarter:
-40.71 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##